These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 5519232)
1. [Naftidrofuryl, a new blood vessel-active substance in the preparation for arterial vascular surgery]. Becker HM Med Klin; 1970 Feb; 65(8):359-61. PubMed ID: 5519232 [No Abstract] [Full Text] [Related]
2. [Clinical experiences with naftidrofuryl in peripheral arterial occlusive diseases]. Hauch E; Lévai Z Med Welt; 1973 Oct; 24(43):1665-6. PubMed ID: 4764064 [No Abstract] [Full Text] [Related]
3. [Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)]. Kriessmann A; Rädler M Munch Med Wochenschr; 1973 Mar; 115(12):508-10. PubMed ID: 4739661 [No Abstract] [Full Text] [Related]
5. [Clinical experience with the new vasoactivator Dusodril. Results of clinical tests and a double-blind experiment]. Bötticher R; Raithel D Med Klin; 1971 Nov; 66(46):1571-3. PubMed ID: 4944892 [No Abstract] [Full Text] [Related]
7. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion]. Heidrich H; Wehselau H Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152 [No Abstract] [Full Text] [Related]
8. [Treatment of primary and secondary Raynaud's syndrome using naftidrofuryl (Dusodril)]. Kriessmann A; Sauer E Dtsch Med J; 1971 Dec; 22(23):743-5. PubMed ID: 5135008 [No Abstract] [Full Text] [Related]
9. [Vasodilator and antibradykinin cutaneous effects of naftidrofuryl measured in man by the thermoconvectance method]. Gautherie M Pathol Biol (Paris); 1972 Jan; 20(1):31-41. PubMed ID: 4552028 [No Abstract] [Full Text] [Related]
10. [Comparison between xenon 133 and thermography in experimental study of a vasodilator agent]. Beurey J; Weber M; Saussure M; Bertrand A; Robert J Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):68-70. PubMed ID: 4565812 [No Abstract] [Full Text] [Related]
11. [Naphthydrofuryl in neurology]. Ahumada BH Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690 [No Abstract] [Full Text] [Related]
12. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril]. Kaufmann J; Förster W Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940 [No Abstract] [Full Text] [Related]
14. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene]. Bornstein S; Sère de Rivières H Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366 [No Abstract] [Full Text] [Related]
15. The role of betahistine hydrochloride in the treatment of peripheral vascular arterial disease. Allison RD; Barnes RN Tex Med; 1971 Nov; 67(11):85-92. PubMed ID: 5001167 [No Abstract] [Full Text] [Related]
16. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis. Gerin J Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345 [No Abstract] [Full Text] [Related]
17. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl]. Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084 [No Abstract] [Full Text] [Related]